ONO Pharmaceutical Co Financial Overview
ONO Pharmaceutical Co's market cap is currently $6.57B. The company's EPS TTM is $0.30658446; its P/E ratio is 18.94; and it has a dividend yield of 4.04%. ONO Pharmaceutical Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.26. See an overview of income statement, balance sheet, and cash flow financials.
